You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis C Genotype 6 (GT 6)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

HCV Microfluidic Diagnostics

Active, not recruiting
  • Hepatitis C
    • Kingston upon Hull, United Kingdom
      University of Hull
    Sep 14, 2023

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +3 more
    • ABT-493 coformulated with ABT-530
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Virus Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

    Recruiting
    • Hepatitis C
    • Epclusa (sofosbuvir and velpatasvir)
    • Guangzhou, Guangdong, China
      Deparment of Infectious Diseases, the Second Affiliated Hospital
    Jul 1, 2021

    Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +2 more
    • (no location specified)
    Jul 9, 2021

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

    Completed
    • Hepatitis C Virus (HCV)
      • Makhachkala, Dagestan, Respublika, Russian Federation
      • +7 more
      Jun 23, 2022

      Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

      Recruiting
      • Chronic Hepatitis C
      • Chronic Hepatitis B
      • Tenofovir Alafenamide 25 MG
      • Sofosbuvir / Velpatasvir
      • Beijing, Beijing, China
        Peking University First Hospital
      Aug 2, 2021

      Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

      Completed
      Has Results
      • Hepatitis C Virus (HCV)
      • San Diego, California
      • +24 more
      Jul 14, 2021

      Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

      Completed
      Has Results
      • Hepatitis C
      • (no location specified)
      Jan 15, 2021

      Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C
      • Hepatitis C Virus
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

      Completed
      Has Results
      • Chronic Hepatitis C
      • Baltimore, Maryland
        Institute of Human Virology University of Maryland
      Apr 26, 2021

      Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult

      Completed
      • Hepatitis C Virus (HCV)
        • Chelyabinsk, Russian Federation
        • +5 more
        Jun 8, 2022

        Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

        Completed
        Has Results
        • Hepatitis C Virus (HCV)
        • Glecaprevir/pibrentasvir adult formulation
        • Glecaprevir/pibrentasvir pediatric formulation
        • San Francisco, California
        • +37 more
        Sep 19, 2022

        Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg

        Completed
        Has Results
        • Chronic Hepatitis C
        • Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
        • Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
        • (no location specified)
        Nov 11, 2019

        Population in Improving Eearly Diagnosis Efficancy in Chinese

        Recruiting
        • Carcinoma, Hepatocellular
        • +4 more
        • Liver cancer surveillance every 3 months
        • +2 more
        • Shanghai, Shanghai, China
          Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
        May 13, 2023

        Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

        Completed
        Has Results
        • Chronic Hepatitis C
        • +2 more
        • (no location specified)
        Jul 9, 2021

        Hepatitis C, Chronic Hepatitis Trial in Melbourne, Barcelona (Daclatasvir, Sofosbuvir)

        Terminated
        Has Results
        • Hepatitis C
        • Chronic Hepatitis
        • Melbourne, Victoria, Australia
        • +1 more
        Apr 16, 2021

        Eliminating HCV Infection Among PWUD

        Recruiting
        • Hepatitis C, Chronic
        • Drug Use
        • Vancouver, British Columbia, Canada
          Vancouver Infectious Diseases Centre
        Jul 22, 2022

        Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

        Completed
        • Hepatitis C, Chronic
        • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
        • Riyadh, Saudi Arabia
          King Fahad Medical City
        Nov 18, 2020

        Hepatitis C Trial in Toronto (HCV care provided by hospitalist during acute psychiatric admission)

        Recruiting
        • Hepatitis C
        • HCV care provided by hospitalist during acute psychiatric admission
        • Toronto, Ontario, Canada
          Centre for Addiction and Mental Health
        Apr 28, 2022